 MASON, Ohio--BUSINESS WIRE--AtriCure, Inc. Nasdaq: ATRC, a leading innovator in surgical treatments for atrial fibrillation Afib, left atrial appendage LAA management, and post-operative pain management, today announced that the company will host an investor education webcast at 2:00 p.m. Eastern Time on Wednesday, September 28, 2022, focusing on Hybrid AF Therapy. The webcast will include remarks from management and key opinion leaders, as well as an interactive question and answer ses 